Search clinical trials for: Theranova 400 dialyzer

Total 12506 results

Baxter Healthcare Corporation

Completed

Comparison of the Clinical Performance of 3 THERANOVA 400 Dialyzer Prototypes With a High-Flux Dialyzer in Hemodialysis Mode

End Stage Renal Disease

Austria
Réseau de Santé Vitalité Health Network

Unknown

Second Clinical Evaluation of THERANOVA-500 Dialyzer in Chronic Hemodialysis (HD)

End Stage Renal Disease on Dialysis

Canada
Baxter Healthcare Corporation

Recruiting

Theranova Randomized, Controlled, Trial (RCT) in China

Acute Kidney Failure | Chronic Kidney Failure

China
Baxter Healthcare Corporation

Completed

Clinical Performance Comparison of 2 THERANOVA 400 Dialyzer Prototypes in HD With High-Flux Dialyzers in HD and hv HDF Mode

End Stage Renal Disease

Germany
Baxter Healthcare Corporation

Completed

Study in End Stage Renal Disease (ESRD) Patients on Hemodialysis to Determine Non-inferiority of the Theranova Dialyzer Compared to the FX80 Dialyzer

End Stage Renal Disease

China
Baxter Healthcare Corporation

Completed

Study in End Stage Renal Disease (ESRD) Patients on Hemodialysis Comparing the Theranova Dialyzer to Hemodiafiltration

End Stage Renal Disease

China
Kyungpook National University Hospital
Baxter Healthcare Corporation; Kyungpook National University Chilgok Hospital; Yeungnam University Hospital and other collaborators

Completed

Theranova Versus High-flux Dialyzer on Preservation of Residual Renal Function (THREAD)

End Stage Renal Disease

Korea, Republic of
Poitiers University Hospital
Baxter Healthcare Corporation

Completed

Comparison of Hemodialysis With Medium Cut-off Dialyzer (Theranova) and High Flux Dialyzer (THERANOVA)

End Stage Renal Disease | Dialysis Related Complication | Dialysis Amyloidosis

France
University of Milan

Unknown

Theranova Dialyzer and Chronic Kidney Disease - Mineral Bone Disorder (CKD-MBD)

Oxidative Stress | End Stage Renal Failure on Dialysis | Vascular Calcification

Italy
The University of Hong Kong
Baxter Healthcare Corporation

Completed

Theranova vs High-flux HD Comparison

End Stage Renal Failure on Dialysis

Hong Kong
Lawson Health Research Institute
Baxter Healthcare Corporation

Completed

Effect of Expanded Dialysis on Patient Reported Symptoms Using LEVIL

End Stage Renal Disease

Canada
Baxter Healthcare Corporation

Completed

Theranova 400 Dialyzer In End Stage Renal Disease (ESRD) Patients

End Stage Renal Disease

United States
Baxter Healthcare Corporation

Completed

Exploratory Study to Explore the Safety and Efficacy of the HDx Therapy Using Theranova 500 Dialyzer in Comparison to Hemodiafiltration

End Stage Renal Disease

Spain
Lawson Health Research Institute
Baxter Healthcare Corporation

Not yet recruiting

An Extension to Assess the Effect of Expanded Dialysis on Patient Reported Symptoms Using LEVIL

End Stage Renal Disease
Technical University of Munich

Unknown

Modulation of Inflammation by Medium Cut Off Membranes (MCO-IF)

Cardiovascular Diseases | End Stage Renal Disease

Germany
Poitiers University Hospital
Hemotech

Completed

Comparison of the Removal of Uremic Toxins With Medium Cut-off and Super High-flux Vitamin E-coated Dialyzers (E-FLUX)

End Stage Renal Disease (ESRD)

France
University of Alberta
University of Calgary

Completed

Examining the Impact of Using Two Dialysers in Parallel on Dialysis Adequacy in Hemodialysis Patients

End Stage Renal Disease

Canada
Medical University of Graz

Completed

Hs-Troponin T Kinetics in Patients Treated With MCO Membranes Compared to High-flux, Low-flux Membranes and HDF

Troponin T

Austria
Gangnam Severance Hospital

Completed

Potential Benefits of Expanded Hemodialysis in Prevention of Sarcopenia

Chronic Kidney Disease Requiring Chronic Dialysis

Korea, Republic of
University of Sao Paulo

Completed

Expanded Hemodialysis Versus Online Hemodiafiltration

Hemodialysis-Induced Symptom | Dialysis Related Complication | Dialysis Hypotension

Brazil
Selayang Hospital

Completed

A Randomised, Open-Label, Cross Over Group, Single-Centre Controlled Study To Evaluate The Clinical Performance Of Medium Cut-Off Membrane Dialyser Compared With High Flux Dialyser Among Patients With Chronic Haemodialysis (HD-1)

Quality of Life | Dialysis Amyloidosis | Hemodialysis-Associated Amyloidosis

Malaysia
Instituto Nacional de Cardiologia Ignacio Chavez
Renal Research Institute

Unknown

Effect of Hemodiafiltration Plus MCOs on Uremic Toxins Removal

Chronic Kidney Disease Requiring Chronic Dialysis | Hemodiafiltration

Mexico
Baxter Healthcare Corporation
German Federal Ministry of Education and Research; Gambro Dialysatoren GmbH

Completed

PERCI- Medium Cut Off (MCO) (PERCI-MCO)

Chronic Inflammation | Chronic Kidney Failure

Germany
Sanliurfa Mehmet Akif Inan Education and Research...

Completed

Investigation of the Effects of Medium Cut-off Dialyzers Versus High-Flux Dialyzers on Clinical and Laboratory Parameters of Prevalent Hemodialysis Patients

Depressive Disorder | Restless Legs Syndrome | Anemia of Chronic Kidney Disease | Hemodialysis-Associated Pruritus | Malnutrition-Inflammation-Cachexia Syndrome

Turkey
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Completed

Tolerability and Pharmacokinetics of CSPCHA115 Capsules in Chinese Healthy Volunteers

Asthma; Allergic Rhinitis

China
Guangdong Zhongsheng Pharmaceutical Co., Ltd.

Completed

The Safety, Tolerability and Pharmacokinetic Study of ZSP1273 in Healthy Volunteers.

Influenza

China
JMackem Co., Ltd
Seoul National University Hospital

Recruiting

A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Oral Administration of AJH-2947 in Healthy Korean and/or Caucasian Adult Male Subjects

Diabetic Neuropathies | Neuropathic Pain | Post Herpetic Neuralgia

Korea, Republic of
Yungjin Pharm. Co., Ltd.

Completed

Safety, Tolerability and Pharmacokinetic Study of KL1333 in Healthy Male Volunteers

MELAS Syndrome | Mitochondrial Respiratory Chain Deficiencies

Korea, Republic of
University College, London

Completed

Clotting With Different Dialyzer Membranes (TAGPSOLACEA)

Kidney Failure
Gannex Pharma Co., Ltd.
Ascletis Pharmaceuticals Co., Ltd.

Recruiting

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASC61in Subjects With Advanced Solid Tumors

Advanced Solid Tumors

United States
Theranova, L.L.C.

Completed

Evaluation of the TheraNova Neuromodulation System to Provide Durable Relief of Overactive Bladder Symptoms

Overactive Bladder

United States
Hospital Clinic of Barcelona
Fresenius Medical Care Deutschland GmbH

Completed

Comparison FX CorDiax 60 in Relation to the FX 60-Dialyzer

Hemodialysis

Spain
Theranova, L.L.C.

Completed

Evaluation of the TheraNova Neuromodulation System for the Treatment of Overactive Bladder Symptoms

Overactive Bladder

United States
Seoul National University Hospital
Samsung Medical Center; Seoul St. Mary's Hospital; Baxter Healthcare Corporation and other collaborators

Completed

Cardiovascular Risk Comparison Between Expanded Hemodialysis Using Theranova and On-line Hemodiafiltration (CARTOON)

Kidney Failure, Chronic | Renal Dialysis

Korea, Republic of
Carlo Maria Guastoni

Unknown

Effect of a Medium Cut-Off Dialyzer - Medical Device on ESA Resistance in 110 Hemodialysis Patients (EXPAND) (EXPAND)

Hemodialysis Complication
Ilkos Therapeutic Inc.

Completed

Dose-response Relationship Study of S42909 on Leg Ulcer Healing

Venous Leg Ulcer

Spain, Hungary, Canada, United States, Brazil, Argentina, Austria, Czechia, Italy, Poland, Slovakia
Royal Free Hampstead NHS Trust

Completed

Study to Assess Clearances and Bio-compatibility of ELISIO Dialyzer

Chronic Kidney Disease

United Kingdom
Fresenius Medical Care Deutschland GmbH

Completed

Comparative Safety and Clinical Performance of Dialyzers Applied During Post-dilution Online Hemodiafiltration (eMPORA II)

Renal Failure | End Stage Renal Disease

Germany
Fresenius Medical Care Deutschland GmbH

Completed

Safety and Clinical Performance of a Dialyzer With a Modified Polysulfone Membrane (eMPORA)

Renal Failure | End Stage Renal Disease

Germany
Aevi Genomic Medicine, LLC, a Cerecor company

Completed

Pharmacokinetic and Tolerability Study of NFC-1 in Subjects Aged 6-17 Years With ADHD

Attention Deficit Disorder With Hyperactivity

United States
St. Louis University

Completed

PFA-100 Responsive to Effect of Energy Drinks on Platelet Function

Thrombosis | Platelet Function

United States
Baxter Healthcare Corporation
Gambro Dialysatoren GmbH

Completed

Performance Comparison of Revaclear With Larger Dialyzer (Revacom HD)

Renal Failure Chronic Requiring Hemodialysis

Austria
Pfizer

Withdrawn

A Study To Evaluate The Safety And Efficacy Of PF-06826647 In Participants With Moderate To Severe Ulcerative Colitis

Ulcerative Colitis

United States
Guangdong Raynovent Biotech Co., Ltd

Completed

Study of ZSP1273 in Patients With Acute Uncomplicated Influenza A

Influenza A

China
GlaxoSmithKline

Completed

A Dose Ranging Study to Evaluate the Safety and Efficacy of GSK2586184 in Patients With Chronic Plaque Psoriasis

Psoriasis

Germany, United Kingdom
Fresenius Medical Care France
Hospices Civils de Lyon

Completed

Continuous Hemodialysis With an Enhanced Middle Molecule Clearance Membrane

Septic Shock

France
CymaBay Therapeutics, Inc.

Completed

Study Investigating the Safety, Tolerability, and PK, PD, of CB-0406

Healthy Volunteers

Australia
EXcorLab GmbH
Nipro Europe N.V.

Completed

Test of the Nipro ELISIO H Dialyzer in Different Dialysis Treatment Procedures

Chronic Kidney Disease

Belgium
Ridgeback Biotherapeutics, LP
Merck Sharp & Dohme LLC

Completed

Safety, Tolerability and Efficacy of Molnupiravir (EIDD-2801) to Eliminate Infectious Virus Detection in Persons With COVID-19

SARS-CoV-2 Infection, COVID-19

United States
Ain Shams University

Completed

To Assess the Effect of HDF Versus High Flux Dialysis on Free Light Chains and Cumulative Albumin Loss, in End Stage Renal Disease Patients.

Hemodialysis | End Stage Renal Disease | Hemodiafiltration

Egypt

Search clinical trials for: Theranova 400 dialyzer

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Czech Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations